Countering Biological Weapons Threats

Countering Biological Weapons Threats

ID: 359216Type: Posted

Overview

Buyer

Bureau of International Security-Nonproliferation (DOS-ISN)

Award Range

$250K - $5M

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359216

Additional Information

https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_d_grant_funding_opportunity&sys_id=af3eb2ce1bb56a50baa70fe4604bcb75&view=Default

Timeline

Description

The Bureau of International Security-Nonproliferation is offering a federal grant opportunity titled "Countering Biological Weapons Threats" aimed at enhancing global biosecurity and preventing the development and use of biological weapons. This initiative seeks to engage various organizations, including U.S. for-profit and non-profit entities, foreign NGOs, and educational institutions, to collaborate on advancing safety and security measures in biological research and biotechnology. The program has an estimated total funding of $15 million, with individual awards ranging from $250,000 to $5 million, and applications are due by July 30, 2025. Interested applicants can find more information and submit inquiries via email at bep@state.gov or through the provided link to the opportunity in MyGrants.

Point(s) of Contact

No information provided.

Files

Title

Size

Type

Posted

737 B

Document

[Content_Types].xml

2 KB

Document

708 B

Document

90 KB

Binary

656 B

Document

2 KB

Document

91 KB

Document

document.xml.rels

2 KB

Document

3 KB

Document

3 KB

Document

3 KB

Document

113 KB

Binary

43 KB

Binary

1 KB

Document

296 B

Document

270 B

Document

296 B

Document

219 B

Document

296 B

Document

17 KB

Document

296 B

Document

1 KB

Document

341 B

Document

335 B

Document

1 KB

Document

30 KB

Binary

17 KB

Document

6 KB

Document

35 KB

Document

7 KB

Document

webSettings.xml

4 KB

Document

Similar Opportunities

Biological Threat Reduction with Global Partners Broad Agency Announcement (BAA)

Defense Threat Reduction Agency

The Defense Threat Reduction Agency (DTRA) has announced a Broad Agency Announcement (BAA) titled "Biological Threat Reduction with Global Partners," aimed at enhancing global health security against biological threats. This initiative invites submissions of Abstracts, White Papers, and Full Proposals from accredited universities, industry, and non-profit organizations to strengthen the capabilities of partner nations in preventing, detecting, and responding to biological threats, including diseases. The BAA emphasizes collaborative scientific studies to improve disease diagnostics, evaluate training programs, and establish biosecurity protocols, ultimately contributing to global biological threat reduction efforts. Interested applicants can find more information and submit proposals through the Grant Opportunities website, with the submission period running from April 29, 2024, to April 28, 2029. For inquiries, contact the CTR BAA Team at dtra.belvoir.ct.mbx.ctr-baa@mail.mil.

Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is offering a grant opportunity titled "Promoting a Basic Understanding of Chemical Threats to Skin," aimed at small businesses interested in researching the pathological mechanisms of skin injuries caused by toxic chemicals. The initiative seeks to elucidate the commonalities in the mechanisms of skin injuries from various vesicants, such as sulfur mustard and Lewisite, with the goal of identifying shared therapeutic targets and developing broad-spectrum medical countermeasures for mass casualty events. The estimated total program funding is $2,500,000, with approximately five awards expected, and interested applicants are encouraged to collaborate and prepare their proposals ahead of the anticipated application period, which is expected to open in early 2026. For further inquiries, potential applicants can contact Dr. Peter J. Koch at Peter.Koch@NIH.gov or by phone at 240-987-8325.

Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics and sequence pathogens to strengthen health protection worldwide

Centers for Disease Control-GHC

The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at enhancing global laboratory systems to manage biological risks and improve health protection worldwide. The initiative focuses on strengthening public health laboratory systems, workforce development, bio risk management, emergency preparedness, laboratory quality management, and enhancing diagnostic capacities, particularly in low-resource settings. This funding opportunity, with an estimated total program funding of $25 million and expected to award three grants, is open to unrestricted applicants, with applications due by January 2, 2026. For further inquiries, interested parties can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.

National Science Foundation

The National Science Foundation (NSF) is offering a grant opportunity titled "Biosensing," aimed at advancing fundamental engineering research in the monitoring, identification, and quantification of biological analytes through innovative technologies at the intersection of engineering, life sciences, and information technology. Proposals are encouraged to address critical sensor needs across various fields, including biomedical research, public health, and environmental protection, with a focus on novel sensing technologies that can adapt to emerging infectious agents and other urgent challenges. The total estimated funding for this program is $7.6 million, with proposals accepted on a rolling basis. Interested applicants can reach out to NSF grants.gov support at grantsgovsupport@nsf.gov for assistance and further details can be found at the NSF program description link.

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support," aimed at providing operational support for NBLs located at the University of Texas Medical Branch in Galveston, Texas, and Boston University in Massachusetts. The funding will support essential services such as facility maintenance, biosecurity, environmental health and safety compliance, and specialized research support, which are critical for conducting research on hazardous biological agents in alignment with NIAID's biodefense and emerging infectious diseases initiatives. With an estimated total program funding of $23 million and the expectation of awarding two grants, interested organizations are encouraged to prepare for application submission, with the anticipated synopsis posting on September 11, 2025, and a closing date of November 10, 2025. For further inquiries, potential applicants can contact Fayna Diaz San Segundo at fayna.diazsansegundo@nih.gov or by phone at 240-921-3931.

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System." This initiative invites applications for basic research projects focused on understanding the mechanisms of toxicity of chemical warfare agents and toxic industrial chemicals that impact the nervous system, with the aim of developing potential therapeutic countermeasures for civilian exposure. The program is particularly significant in enhancing public health responses to chemical threats, emphasizing innovative and transdisciplinary research approaches. Up to four grants totaling $2 million are anticipated for fiscal year 2026, with applications due by 5 PM local time on October 17, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

National Institutes of Health

The National Institutes of Health (NIH) is inviting applications for the CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) program, focusing on basic research related to chemical warfare agents and toxic industrial chemicals that impact the nervous system. The objective is to elucidate mechanisms of toxicity, identify biological markers, and develop potential therapeutic countermeasures for civilian populations exposed to these chemicals. This funding opportunity is critical for enhancing public safety against chemical threats, with a total of $2 million available for up to four awards, each with a maximum annual budget of $300,000 over three years. Interested applicants must submit their proposals by September 17, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.

Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases

Centers for Disease Control - NCEZID

The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.

Infrastructure Innovation for Biological Research

National Science Foundation

The National Science Foundation (NSF) is offering a grant opportunity titled "Infrastructure Innovation for Biological Research," aimed at supporting research that develops novel or significantly improved tools and methods in contemporary biology. This program seeks proposals that focus on enhancing research infrastructure in three key areas: Bioinformatics, Instrumentation, and Research Methods, with the goal of advancing biological understanding and addressing fundamental research questions. The total estimated funding for this program is $18 million, with individual awards ranging from $300,000 to $800,000, and proposals can be submitted at any time. Interested applicants can reach out to NSF grants.gov support at grantsgovsupport@nsf.gov for assistance and further details can be found in NSF Publication 23-578.

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

National Institutes of Health

The National Institutes of Health (NIH) is offering a funding opportunity through the Blueprint Neurotherapeutics Network (BPN) for Biologics, aimed at supporting biologic-based drug discovery and development for disorders of the nervous system. This initiative invites applications from U.S.-based small businesses to develop diverse therapeutic modalities, including antibodies and gene therapies, with a focus on specific nervous system disorders and a requirement for preliminary data demonstrating efficacy. The program emphasizes a phased, milestone-driven cooperative agreement, facilitating the transition of promising biotherapeutics from lead optimization to first-in-human trials while ensuring regulatory compliance and effective intellectual property management. Applications are due by January 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-294.html.